Pharmacodynamic Blood Characteristics of ICP-332 in Patients With Moderate to Severe Atopic Dermatitis
Clinical trial NCT05702268 · UNKNOWN
Trial details
- NCT number
- NCT05702268
- Sponsor
- Beijing InnoCare Pharma Tech Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-03-18
- Primary completion
- 2023-07-30
- Enrollment
- 75
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.